AFA
BMY icon

Abacus FCF Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Abacus FCF Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1M Buy
227,584
+3,584
+2% +$206K 2.41% 11
2026
Q1 		$13.6M Sell
224,000
-161,100
-42% -$9.39M 3.06% 4
2025
Q4 		$20.8M Buy
385,100
+8,950
+2% +$431K 2.71% 6
2025
Q3 		$17M Buy
376,150
+10,740
+3% +$502K 2.25% 17
2025
Q2 		$16.9M Buy
365,410
+73,911
+25% +$3.63M 2.37% 15
2025
Q1 		$17.8M Buy
291,499
+88,141
+43% +$5.14M 2.79% 7
2024
Q4 		$11.5M Buy
203,358
+81,017
+66% +$4.53M 1.51% 13
2024
Q3 		$6.33M Buy
122,341
+9,496
+8% +$445K 1.47% 13
2024
Q2 		$4.69M Buy
112,845
+2,440
+2% +$109K 1.16% 16
2024
Q1 		$5.99M Buy
110,405
+8,095
+8% +$412K 1.5% 15
2023
Q4 		$5.25M Buy
102,310
+67,856
+197% +$3.56M 1.52% 11
2023
Q3 		$2M Sell
34,454
-536
-2% -$32.8K 1.06% 19
2023
Q2 		$2.24M Buy
34,990
+5,076
+17% +$340K 1.13% 17
2023
Q1 		$2.07M Buy
29,914
+7,986
+36% +$563K 1.11% 17
2022
Q4 		$1.58M Sell
21,928
-492
-2% -$37.1K 1.03% 23
2022
Q3 		$1.59M Sell
22,420
-4,075
-15% -$296K 1.1% 11
2022
Q2 		$2.04M Sell
26,495
-30,564
-54% -$2.33M 1.25% 15
2022
Q1 		$4.17M Buy
57,059
+32,786
+135% +$2.2M 1.39% 9
2021
Q4 		$1.51M Hold
24,273
– – 0.74% 52
2021
Q3 		$1.46M Hold
24,273
– – 0.71% 53
2021
Q2 		$1.62M Buy
+24,273
New +$1.58M 0.83% 38

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Abacus FCF Advisors's BMY Position: Q2 2026 in Review

Abacus FCF Advisors increased its Bristol-Myers Squibb (BMY) stake by 1.6% in Q2 2026, buying an estimated $206K and bringing the position to 227,584 shares worth $13.1M. The position accounts for 2.41% of the portfolio, ranked #11.

Abacus FCF Advisors first reported a position in BMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $20.8M in Q4 2025. 2,516 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Abacus FCF Advisors held 227,584 shares of Bristol-Myers Squibb worth $13.1M as of Q2 2026.
  • Abacus FCF Advisors bought 3,584 Bristol-Myers Squibb shares in Q2 2026, an estimated $206K.
  • Bristol-Myers Squibb made up 2.41% of Abacus FCF Advisors's portfolio in Q2 2026, its #11 holding.
  • Abacus FCF Advisors first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 21 quarters since.
  • Abacus FCF Advisors's Bristol-Myers Squibb position peaked at $20.8M in Q4 2025.
  • 2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Abacus FCF Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.